Faculty

Institution

Unit

Venue

Ian Zagon

Distinguished Professor

Pennsylvania State University

Affiliations

Penn State College of Medicine

Department of Neural and Behavioral Sciences

Ian Zagon is currently serving as a Neural And Behavioral Sciences Distinguished Professor at Pennsylvania State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ian Zagon

Pennsylvania State University

Distinguished Professor

You can click a keyword to filter the displayed items

pharmacology neuroscience neurology physiology oncology medicinal research mammalian biology opioid growth factor neuropharmacology cancer biology cancer research tumor biology brain science neuroanatomy developmental neurobiology endocrinology cancer treatment pharmacotherapy experimental medicine receptors cancer care experimental biology vascular biology pancreatic cancer pharmacological research cellular physiology animal physiology human physiology comparative physiology cell regulation experimental pharmacology molecular physiology applied physiology cell proliferation endogenous opioids experimental therapeutics anti-cancer agents addiction biology avian biology ocular surface vision research diabetic rats gynecologic oncology respiratory medicine oral cancer tumor targeting clinical gastroenterology human pancreatic cancer experimental autoimmune encephalomyelitis physiological research cancer management experimental ophthalmology therapeutic efficacy cutaneous biology endogenous opioid systems opioid antagonist naltrexone receptor (biochemistry) neck oncology drug targeting mammalian physiology cancer growth brain spectrin colorectal cancer opioid overdose perinatal methadone exposure ogf-ogfr axis tissue physiology drug treatment human cancer cells dna synthesis adult rats rat cerebellum opioid receptors retina neuropeptides human ovarian cancer opioid epidemic wound healing addiction medicine translational medicine rheumatism medicine diabetes therapies

Notable Scholarly Works

Notable Federal Grants

Collaborators

Topical Naltrexone Increases Aquaporin 5 Production in the Lacrimal Gland and Restores Tear Production in Diabetic Rats. Experimental Biology and Medicine (2024)

David DiazJoseph P SassaniIan S ZagonPatricia J McLaughlin

experimental dermatologydrug metabolismdiabetesmammalian biologyophthalmologyexperimental biologylacrimal glanddiabetic ratstopical naltrexonelaboratory medicinevascular biologyphysiologyexperimental botanyinflammationendocrinologydermatologyregenerative medicineexperimental pharmacologyexperimental medicineexperimental ophthalmology

A Review of Factors Influencing Anxiety and Depression in Persons With Multiple Sclerosis During the Covid-19 Pandemic. Medical Research Archives (2023)

Patricia McLaughlinLaura OdomIan Zagon

clinical psychiatrypsychiatrymedicinecovid-19 pandemicmental healthdepressionhealth psychologymultiple sclerosispsychologyclinical psychologymedicinal research

Elevated Opioid Growth Factor Alters the Limbus in Type 1 Diabetic Rats. Journal of Diabetes and Clinical Research (2023)

Patricia J. McLaughlinJoseph W. SassaniDavid DiazIan S. Zagon

opioid growth factordiabetesdiabetic ratsdermatologypharmacologyaddictionmammalian biologyneurologymedicinal research

Length of Disease More Than Therapy Impacts Anxiety and Depression in Multiple Sclerosis. Neurology and Neuroscience (2023)

Patricia J McLaughlinLaura B OdomPeter A ArnettGary A ThomasShannon OrehekIan S Zagon

therapeutic relationshippsychiatrytreatment goalsclinical neurosciencemental healthneuroscienceanxiety disordersdepressionneuropsychologyclinical neurologytherapy impacts anxietyneuropsychiatrymultiple sclerosisneurology

Safety Study of Topical Naltrexone Therapy for Diabetic Skin Wounds is Confirmed in GöTtingen Mini‐Pigs. Drug Development Research (2023)

Patricia J. McLaughlinJoseph W. SassaniIan S. Zagon

diabetic skin woundsmedicinediabetesinflammationveterinary medicinedrug developmentdermatologysafety studypharmacologytopical naltrexone therapygottingen mini-pigsdrug safety

Low-Dose Naltrexone Reduced Anxiety in Persons With Multiple Sclerosis During the Covid-19 Pandemic. International Immunopharmacology (2022)

Patricia J. McLaughlinLaura B. OdomPeter A. ArnettShannon OrehekGary A. ThomasIan S. Zagon

psychiatrylow-dose naltrexoneimmunologypharmacologypsychopharmacologymultiple sclerosis

Maintenance of [Met5]-Enkephalin Blood Levels Corresponds With a Positive Outcome in Multiple Sclerosis. Journal of Experimental Neurology (2022)

Patricia MclaughlinIan Zagon

positive outcomepharmacologymultiple sclerosisneurologyhealth sciences

Sex Differences in Diabetic Ocular Surface Complications and Dysregulation of the Ogf-Ogfr Pathway. Journal of Diabetes and Clinical Research (2022)

Ian S ZagonJoseph W SassaniPatricia J McLaughlin

diabetesophthalmologyogf-ogfr pathway

Dysregulation of the Ogf-Ogfr Pathway and Associated Diabetic Complications. Journal of Diabetes and Clinical Research (2021)

Patricia J McLaughlinJoseph W SassaniIan S Zagon

hematologydiabetesdiabetic complicationsogf-ogfr pathwayhealth sciences

Naltrexone Blockade of Ogfr Enhances Cutaneous Wound Closure in Diabetic Rats. Medicine in Drug Discovery (2021)

Patricia J. McLaughlinJoseph W. SassaniIndira PurushothamanIan S. Zagon

clinical evidencemedicinediabetespharmacologyophthalmologycutaneous biologywound healingwound caredrug discoveryveterinary medicinediabetic ratsvascular biologydiabetes therapiesmedicinal researchregenerative medicineexperimental pharmacologyclinical pharmacologyexperimental medicinepharmacotherapy

1
2
3
4
5
37
10 / page

Ian Zagon

Distinguished Professor

Pennsylvania State University

Affiliations

Penn State College of Medicine

Department of Neural and Behavioral Sciences

Ian Zagon is currently serving as a Neural And Behavioral Sciences Distinguished Professor at Pennsylvania State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ian Zagon

Pennsylvania State University

Distinguished Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Topical Naltrexone Increases Aquaporin 5 Production in the Lacrimal Gland and Restores Tear Production in Diabetic Rats. Experimental Biology and Medicine (2024)

David DiazJoseph P SassaniIan S ZagonPatricia J McLaughlin

A Review of Factors Influencing Anxiety and Depression in Persons With Multiple Sclerosis During the Covid-19 Pandemic. Medical Research Archives (2023)

Patricia McLaughlinLaura OdomIan Zagon

clinical psychiatrypsychiatrymedicinecovid-19 pandemicmental healthdepressionhealth psychologymultiple sclerosispsychologyclinical psychologymedicinal research

Elevated Opioid Growth Factor Alters the Limbus in Type 1 Diabetic Rats. Journal of Diabetes and Clinical Research (2023)

Patricia J. McLaughlinJoseph W. SassaniDavid DiazIan S. Zagon

opioid growth factordiabetesdiabetic ratsdermatologypharmacologyaddictionmammalian biologyneurologymedicinal research

Length of Disease More Than Therapy Impacts Anxiety and Depression in Multiple Sclerosis. Neurology and Neuroscience (2023)

Patricia J McLaughlinLaura B OdomPeter A ArnettGary A ThomasShannon OrehekIan S Zagon

Safety Study of Topical Naltrexone Therapy for Diabetic Skin Wounds is Confirmed in GöTtingen Mini‐Pigs. Drug Development Research (2023)

Patricia J. McLaughlinJoseph W. SassaniIan S. Zagon

diabetic skin woundsmedicinediabetesinflammationveterinary medicinedrug developmentdermatologysafety studypharmacologytopical naltrexone therapygottingen mini-pigsdrug safety

Low-Dose Naltrexone Reduced Anxiety in Persons With Multiple Sclerosis During the Covid-19 Pandemic. International Immunopharmacology (2022)

Patricia J. McLaughlinLaura B. OdomPeter A. ArnettShannon OrehekGary A. ThomasIan S. Zagon

psychiatrylow-dose naltrexoneimmunologypharmacologypsychopharmacologymultiple sclerosis

Maintenance of [Met5]-Enkephalin Blood Levels Corresponds With a Positive Outcome in Multiple Sclerosis. Journal of Experimental Neurology (2022)

Patricia MclaughlinIan Zagon

positive outcomepharmacologymultiple sclerosisneurologyhealth sciences

Sex Differences in Diabetic Ocular Surface Complications and Dysregulation of the Ogf-Ogfr Pathway. Journal of Diabetes and Clinical Research (2022)

Ian S ZagonJoseph W SassaniPatricia J McLaughlin

diabetesophthalmologyogf-ogfr pathway

Dysregulation of the Ogf-Ogfr Pathway and Associated Diabetic Complications. Journal of Diabetes and Clinical Research (2021)

Patricia J McLaughlinJoseph W SassaniIan S Zagon

hematologydiabetesdiabetic complicationsogf-ogfr pathwayhealth sciences

Naltrexone Blockade of Ogfr Enhances Cutaneous Wound Closure in Diabetic Rats. Medicine in Drug Discovery (2021)

Patricia J. McLaughlinJoseph W. SassaniIndira PurushothamanIan S. Zagon

1
2
3
4
5
37
10 / page

Similar Faculty Members

Patricia McLaughlin

Institution

Pennsylvania State University

pharmacological research

opioid growth factor

Barbara Slusher

Institution

Johns Hopkins University

pharmacology

neuroscience

Sanjay Srivastava

Institution

University of Louisville

volatile organic compounds

free radical biology

James R. Goldenring

Institution

Vanderbilt University

gastrointestinal oncology

gastroenterology

Aleksander S. Popel

Institution

Johns Hopkins University

vascular biology

physiology

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Andrzej S. Tarnawski

Institution

University of California, Irvine

stem cell

biomedical informatics

Adhip Majumdar

Institution

Wayne State University

pharmacology

oncology

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Antonio Giordano

Institution

Temple University

oncology

cancer research

Similar Faculty Members

Patricia McLaughlin

Institution

Pennsylvania State University

pharmacological research

opioid growth factor

Barbara Slusher

Institution

Johns Hopkins University

pharmacology

neuroscience

Sanjay Srivastava

Institution

University of Louisville

volatile organic compounds

free radical biology

James R. Goldenring

Institution

Vanderbilt University

gastrointestinal oncology

gastroenterology

Aleksander S. Popel

Institution

Johns Hopkins University

vascular biology

physiology

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Andrzej S. Tarnawski

Institution

University of California, Irvine

stem cell

biomedical informatics

Adhip Majumdar

Institution

Wayne State University

pharmacology

oncology

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Antonio Giordano

Institution

Temple University

oncology

cancer research